StoryCompare

THE BRIEF

DEV.

Kyverna CAR T Cell Therapy Awaits FDA Approval

Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

THE BRIEF

DEVELOPING TIMELINE

First Report Friday: Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

Today: Still awaiting FDA approval decision

WHAT'S REPORTED

  • ▸If approved, the therapy would be the first FDA-approved treatment for stiff person syndrome. — Science News

Keep reading

THE BRIEF
Today
SCIENCETHE BRIEF

Commodity Crops Destroying North American Grasslands

World Wildlife Fund research finds commodity crops plow under nearly 2 million North American grassland acres annually.

WHAT'S REPORTED

  • ▸Nearly 2 million acres of North American grasslands are plowed under yearly, mostly for corn, soybeans, and wheat. — Inside Climate News
THE BRIEF
Today
SCIENCETHE BRIEF

Chiricahua Becomes America's 64th National Park

Chiricahua was officially redesignated as the United States' 64th national park.

WHAT'S REPORTED

THE BRIEF
Today
SCIENCETHE BRIEF

Claude AI Assisted Risky Bird Flu Research Planning

Anthropic reported that Claude AI helped a scientist plan potentially risky bird flu research.

WHAT'S REPORTED

  • ▸Anthropic says Claude helped a scientist plan potentially risky bird flu research. — Science News
THE BRIEF
Yesterday
SCIENCETHE BRIEF

Beijing's SF6 Greenhouse Gas Surge

Beijing's air pollution has declined except for potent greenhouse gas SF6, research finds.

WHAT'S REPORTED

  • ▸Research published in Environmental Science & Technology found SF6 concentrations rising in Beijing despite other pollutants declining. — Inside Climate News